Btai short interest
WebShort Interest 3.27M 03/15/23 % of Float Shorted 46.70% Average Volume 10.5M Performance Analyst Ratings Sell Under Hold Over Buy Number of Ratings 3 Full Ratings Recent News MarketWatch Dow... WebFind the latest on short interest for BioXcel Therapeutics, Inc. Common Stock (BTAI) at Nasdaq.com. BioXcel Therapeutics, Inc. Common Stock (BTAI) Short Interest Nasdaq …
Btai short interest
Did you know?
WebBarchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. After each calculation, the program assigns a buy, sell or hold value for each study ... WebApr 11, 2024 · Short Interest Social Media Sustainability BioXcel Therapeutics Consensus Rating and Price Target (2024) Consensus Analyst Rating Moderate Buy Based on 8 Analyst Ratings Consensus Analyst Price Target $53.33 185.82% Upside Get BioXcel Therapeutics Upgrade and Downgrade Alerts
WebMar 6, 2024 · BioXcel Therapeutics Stock (NASDAQ:BTAI), Short Interest Report Short interest for BioXcel Therapeutics gives investors a sense of the degree to which … WebBioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile. ... Profile News Analyst Ratings Guidance Dividends Earnings Insider Trades Ideas Short Interest. 0.
WebApr 11, 2024 · Short Selling Information The latest short interest is 2.45 million, so 8.76% of the outstanding shares have been sold short. Income Statement In the last 12 months, BTAI had revenue of $137,000 and -$137.07 million in losses. Loss per share was -$4.88. Full Income Statement Balance Sheet WebShort interest as a percentage of float above 20% is extremely high. The NYSE short interest ratio has been gradually falling since the late 1990s. So no long-term level can be identified as “high.”. But over the short-run, a spike upwards can indicate pessimistic sentiment towards the economy as a whole.
WebFind real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. scoundrel\\u0027s 30WebMar 8, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) saw a significant growth in short interest in February. As of February 15th, there was short interest … scoundrel\\u0027s 3iWeb1 day ago · JPMorgan Chase, the nation’s largest bank, offers customers a one-year CD of $9,999 that carries a 3.0% annual rate. Alas, if you want to cash in the CD early, then … scoundrel\\u0027s 3hWebBTAI / BioXcel Therapeutics Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED Overview Owners Insiders Short Interest Options Filings Financials Dividends Earnings Forecast SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. scoundrel\\u0027s 3oWeb2 days ago · 005930. SAMSUNG ELECTRON. 66,100.00. KRW. +100.00 +0.15%. When it comes to the world’s second-largest maker of memory chips, analysts and short sellers are poles apart. A week after a spike in ... scoundrel\\u0027s 3yWebBioXcel Therapeutics Short Interest Distribution For the Biotechnology industry and Healthcare sector, BioXcel Therapeutics's Short Interest distribution charts can be found … scoundrel\\u0027s 3tWebBioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Crypto Dow 30 Russell 2000 Crude Oil (-0.30%) BioXcel Therapeutics, Inc. (BTAI) NasdaqCM -... scoundrel\\u0027s 3s